This topic has 1 voice and 0 replies. Viewing 0 reply threads Author Posts September 7, 2018 at 7:23 am #13674 Pulmonary Hypertension News ModeratorParticipant United Therapeutics and MannKind have established an exclusive licensing and collaboration agreement to develop treprostinil-Technosphere device for PAH treatment. Click here to read more about this story. What are your thoughts on this news? Author Posts Viewing 0 reply threads You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Log In